Collegium Pharmaceutical’s Oxycodone DETERx(R), an Abuse-Deterrent, Extended-Release Opioid, to be featured at PAINWeek 2013 by longitudeadmin | Sep 3, 2013 | Portfolio News
Esperion Therapeutics Announces Positive Top-Line Results from Phase 2 Clinical Study of ETC-1002 as an Add-On to Statin Therapy in Patients with Hypercholesterolemia by longitudeadmin | Sep 3, 2013 | Portfolio News
Ovarian Cancer Chemoresponse Assay Demonstrates Utility by longitudeadmin | Aug 20, 2013 | Portfolio News
Cadence Pharmaceuticals Comments on USPTO’s Non-Final, Initial Office Action on Reexamination of Patent by longitudeadmin | Aug 15, 2013 | Portfolio News
Corcept Therapeutics announces partnership with Idis for global access to Korlym® by longitudeadmin | Jul 24, 2013 | Portfolio News
